2Ana Conde-Rosa, Rosana Amador, Doris Perez-Torres, et al. Candidemia distribution, associated risk factors, and attributed mortality at a universi- ty-based medical center[J]. P R Health Sci J,2010 ;29( 1 ) :26-9.
3Sheppard DC ,Rieg G. Novel inhalational murine model of invasive pulmo- nary aspergillosis [J]. Antimicrob Age Chemother,2004 ;48 (5) : 1908-11.
4Ashman RB, Vijayan D, Wells CA. IL-12 and related 'cytokines : function and regulatory implications in Candida albicmls infection[J]. Clin Devel Immuno1,2011 ;2011:686597.
5Mitra S, Dolan K, Foster TH, et al. Imaging morphogenesis of Candida albicans during infection in a live animal [J]. Biomedi Optics,2010;15(1) :104-5.
6Tsuchimori N, Sharkey LL, Fonzi WA,et al. Redued virulence of HWP1- deficient mutants of candida albicans and their interactions with host cells[J]. Infec [mmun,2000 ;68 (4) : 1997-2002.
7Xu XL, Zhu Y, Wang Y. Bacterial peptidoglycan triggers eandida albi- cans hyphal growth by directly activating the adenylyl cyclase Cyrl p [J] Cell Host & Microb,2008 ;4( 1 ) :28-39.
8Klengel T, Liang WJ, Chaloupka J, et al. Fungal adenylyl eyelase in- tegrates CO2 sensing with cAMP signaling and virulence[ J]. Curr Biol, 2005 ;15(22) :2021-6.
9Gasparoto TH ,Tessarolli V. Absence of functional TLR4 impairs of mac- rophages after Candida albicans infection [J] . Med Mycol, 2010 ; 48 (8) :1009-17.
10Huang W, Na L, Fidel PL, et al. Requirement of IL-17A for systemic an- ti-Candida albicans host defense in mice [J]. J Infect Dis, 2004;190 (3) :624-31.
